tiprankstipranks
Trending News
More News >
Eris Lifesciences Ltd (IN:ERIS)
:ERIS
India Market

Eris Lifesciences Ltd (ERIS) Financial Statements

Compare
0 Followers

Eris Lifesciences Ltd Financial Overview

Eris Lifesciences Ltd's market cap is currently ₹205.02B. The company's EPS TTM is ₹8.8; its P/E ratio is 49.31; and it has a dividend yield of 0.47%. Eris Lifesciences Ltd is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is ₹9.77. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 28.79B₹ 19.91B₹ 16.62B₹ 13.26B₹ 11.93B
Gross Profit₹ 21.49B₹ 9.95B₹ 13.09B₹ 10.65B₹ 9.51B
Operating Income₹ 16.60B₹ 4.95B₹ 4.29B₹ 4.31B₹ 3.96B
EBITDA₹ 10.17B₹ 6.99B₹ 5.48B₹ 5.11B₹ 4.39B
Net Income₹ 3.52B₹ 3.92B₹ 3.82B₹ 4.06B₹ 3.55B
Balance Sheet
Cash & Short-Term Investments₹ 2.28B₹ 13.39B₹ 892.43M₹ 2.12B₹ 1.31B
Total Assets₹ 70.33B₹ 70.49B₹ 36.67B₹ 22.72B₹ 18.35B
Total Debt₹ 24.78B₹ 27.81B₹ 8.77B₹ 844.07M₹ 67.77M
Net Debt₹ 22.55B₹ 26.87B₹ 8.21B₹ 336.13M₹ -300.93M
Total Liabilities₹ 37.61B₹ 38.27B₹ 14.47B₹ 3.64B₹ 2.58B
Stockholders' Equity₹ 28.54B₹ 25.86B₹ 21.96B₹ 19.08B₹ 15.76B
Cash Flow
Free Cash Flow₹ 9.10B₹ 3.57B₹ -5.50B₹ 2.57B₹ 3.50B
Operating Cash Flow₹ 10.65B₹ 4.86B₹ 2.92B₹ 3.78B₹ 3.75B
Investing Cash Flow₹ -799.70M₹ -18.55B₹ -9.82B₹ -3.20B₹ -3.23B
Financing Cash Flow₹ -8.81B₹ 13.80B₹ 6.88B₹ -446.99M₹ -823.95M
Currency in INR

Eris Lifesciences Ltd Earnings and Revenue History

Eris Lifesciences Ltd Debt to Assets

Eris Lifesciences Ltd Cash Flow

Eris Lifesciences Ltd Forecast EPS vs Actual EPS